---
figid: PMC3857153__nihms442997f8
figlink: /pmc/articles/PMC3857153/figure/F8/
number: Fig 8
caption: '(A) Regarding the Fas/TNFα-mediate apoptosis pathway, fenretinide up-regulated
  the expression of three pro-apoptotic genes including DEDD, CASP8, and CASP4, which
  subsequently triggered the pathway; Additionally, fenretinide also induced apoptosis
  by up-regulating pro-apoptotic genes HSPA1A/B, which is activated by ER stress and
  promotes TNF-mediated apoptosis. In contrast, ATRA induced the expression of two
  anti-apoptotic genes BIRC3 and TNFAIP3, which negatively regulated the Fas/TNFα-mediate
  signaling pathway, and eventually inhibited Fas/TNFα-mediated apoptosis. The repressed
  expression of PCSK9, which play an important role in caspase-3 activation, also
  decreased ATRA-mediated apoptosis. (B) Regarding the RAS/RAF/ERK-medicated survival
  pathway, fenretinide repressed the expression of BRAF, and therefore decreased the
  expression levels of MEK1 and ERK2, which finally inhibited cell survival. Conversely,
  ATRA up-regulated the expression of SOSC2, successively increased the expression
  of three key genes: BRAF, MEK1 and ERK2, and therefore induced the RAS/RAF/ERK-mediated
  survival pathway. Additionally, ATRA promoted the NFkB-dependent survival pathway
  by repressing CITE2 gene expression. “→” indicates induction and “⊥” indicates repression.
  The genes marked in green circle indicate pro-apoptosis genes. The genes marked
  in red circle indicate anti-apoptosis genes. The numbers in bracket represent the
  fold-change of gene expression changed by fenretinide or ATRA at corresponding time-point.'
pmcid: PMC3857153
papertitle: Transcriptome profiling and genome-wide DNA binding define the differential
  role of fenretinide and all-trans RA in regulating the death and survival of human
  hepatocellular carcinoma Huh7 cells.
reftext: Ying Hu, et al. Biochem Pharmacol. ;85(7):10.1016/j.bcp.2013.01.023.
pmc_ranked_result_index: '71819'
pathway_score: 0.9023805
filename: nihms442997f8.jpg
figtitle: Transcriptome profiling and genome-wide DNA binding define the differential
  role of fenretinide and all-trans RA in regulating the death and survival of human
  hepatocellular carcinoma Huh7 cells
year: ''
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3857153__nihms442997f8.html
  '@type': Dataset
  description: '(A) Regarding the Fas/TNFα-mediate apoptosis pathway, fenretinide
    up-regulated the expression of three pro-apoptotic genes including DEDD, CASP8,
    and CASP4, which subsequently triggered the pathway; Additionally, fenretinide
    also induced apoptosis by up-regulating pro-apoptotic genes HSPA1A/B, which is
    activated by ER stress and promotes TNF-mediated apoptosis. In contrast, ATRA
    induced the expression of two anti-apoptotic genes BIRC3 and TNFAIP3, which negatively
    regulated the Fas/TNFα-mediate signaling pathway, and eventually inhibited Fas/TNFα-mediated
    apoptosis. The repressed expression of PCSK9, which play an important role in
    caspase-3 activation, also decreased ATRA-mediated apoptosis. (B) Regarding the
    RAS/RAF/ERK-medicated survival pathway, fenretinide repressed the expression of
    BRAF, and therefore decreased the expression levels of MEK1 and ERK2, which finally
    inhibited cell survival. Conversely, ATRA up-regulated the expression of SOSC2,
    successively increased the expression of three key genes: BRAF, MEK1 and ERK2,
    and therefore induced the RAS/RAF/ERK-mediated survival pathway. Additionally,
    ATRA promoted the NFkB-dependent survival pathway by repressing CITE2 gene expression.
    “→” indicates induction and “⊥” indicates repression. The genes marked in green
    circle indicate pro-apoptosis genes. The genes marked in red circle indicate anti-apoptosis
    genes. The numbers in bracket represent the fold-change of gene expression changed
    by fenretinide or ATRA at corresponding time-point.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CASP14
  - CASP2
  - CASP4
  - CASP5
  - MYC
  - CASP1
  - CASP3
  - CASP12
  - KRAS
  - CASP6
  - BRAF
  - HRAS
  - CITED2
  - PIK3CA
  - MAPK1
  - TRAF2
  - PIK3CG
  - PIK3R3
  - IGF1
  - PIK3CB
  - CASP10
  - TNF
  - BIRC3
  - TNFRSF1A
  - NRAS
  - PIK3CD
  - PIK3R5
  - TNFSF10
  - RASA2
  - CASP7
  - FASLG
  - TNFAIP3
  - MAP2K1
  - SOCS2
  - PIK3R4
  - PIK3R6
  - PCSK9
  - CASP8
  - RASA3
  - RASA1
  - IGF1R
  - CASP9
  - NFKB1
  - Fenretinide
  - Cancer
  - Lung cancer
  - Noonan syndrome
genes:
- word: Caspases
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP14
  entrez: '23581'
- word: Caspases
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP2
  entrez: '835'
- word: Caspases
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP4
  entrez: '837'
- word: Caspases
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP5
  entrez: '838'
- word: C-myc
  symbol: c-Myc
  source: hgnc_alias_symbol
  hgnc_symbol: MYC
  entrez: '4609'
- word: Caspases
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP1
  entrez: '834'
- word: Caspases
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP3
  entrez: '836'
- word: Caspases
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP12
  entrez: '100506742'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: Caspases
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP6
  entrez: '839'
- word: BRAF
  symbol: BRAF
  source: hgnc_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: CITED2
  symbol: CITED2
  source: hgnc_symbol
  hgnc_symbol: CITED2
  entrez: '10370'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: ERK2
  symbol: ERK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: TRAF2
  symbol: TRAF2
  source: hgnc_symbol
  hgnc_symbol: TRAF2
  entrez: '7186'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: IGF-1
  symbol: IGF1
  source: hgnc_symbol
  hgnc_symbol: IGF1
  entrez: '3479'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: Caspases
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP10
  entrez: '843'
- word: TNF
  symbol: TNF
  source: hgnc_symbol
  hgnc_symbol: TNF
  entrez: '7124'
- word: BIRC3
  symbol: BIRC3
  source: hgnc_symbol
  hgnc_symbol: BIRC3
  entrez: '330'
- word: TNFR
  symbol: TNF-R
  source: hgnc_alias_symbol
  hgnc_symbol: TNFRSF1A
  entrez: '7132'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: (TRAIL
  symbol: TRAIL
  source: hgnc_alias_symbol
  hgnc_symbol: TNFSF10
  entrez: '8743'
- word: RasA
  symbol: RASA
  source: bioentities_symbol
  hgnc_symbol: RASA2
  entrez: '5922'
- word: Caspases
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP7
  entrez: '840'
- word: Fasl
  symbol: FasL
  source: hgnc_alias_symbol
  hgnc_symbol: FASLG
  entrez: '356'
- word: TNFAIP3
  symbol: TNFAIP3
  source: hgnc_symbol
  hgnc_symbol: TNFAIP3
  entrez: '7128'
- word: MEK1
  symbol: MEK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: SOCS2
  symbol: SOCS2
  source: hgnc_symbol
  hgnc_symbol: SOCS2
  entrez: '8835'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PCSK9
  symbol: PCSK9
  source: hgnc_symbol
  hgnc_symbol: PCSK9
  entrez: '255738'
- word: Caspases
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP8
  entrez: '841'
- word: RasA
  symbol: RASA
  source: bioentities_symbol
  hgnc_symbol: RASA3
  entrez: '22821'
- word: RasA
  symbol: RASA
  source: bioentities_symbol
  hgnc_symbol: RASA1
  entrez: '5921'
- word: IGFR
  symbol: IGFR
  source: hgnc_alias_symbol
  hgnc_symbol: IGF1R
  entrez: '3480'
- word: Caspases
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP9
  entrez: '842'
- word: NF-KB
  symbol: NF-kappaB
  source: hgnc_alias_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
chemicals:
- word: Fenretinide
  source: MESH
  identifier: D017313
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
---
